COMMUNIQUÉS West-GlobeNewswire

Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hematology (ASH) Annual Meeting in 16 Relapsed/Refractory AL Amyloidosis Patients

25/11/2024 - 15:32

75% (12/16) complete response rate observed in relapsed/refractory AL Amyloidosis patients with median 4 prior lines of therapy Data will be presented on Monday, December 9, 2024 at 4:00 PM PT LOS ANGELES, Nov. 25, 2024 [...]

Cannara Biotech Inc. annonce ses résultats pour le quatrième trimestre et l’exercice 2024 : Augmentation record des ventes et du flux de trésorerie d'exploitation, renforçant sa position de leader sur le marché canadien du cannabis

25/11/2024 - 15:31

Total des produits records au quatrième trimestre et pour l’exercice 2024 : 23,4 millions de dollars et 82,2 millions de dollars, soit une augmentation de 28 % et 43 % par rapport aux mêmes périodes en 2023. Croissance [...]

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

25/11/2024 - 15:30

Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023. Robust growth in Q4 over Q3 2024, with total revenues increasing by 20 [...]

Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients

25/11/2024 - 15:15

WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial SOUTH JORDAN, Utah, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a [...]

BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™

25/11/2024 - 15:15

LAS VEGAS, Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) received approval today for a human clinical trial of its weight management product, Zeranovia™ . The trial, approved by an [...]

Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24

25/11/2024 - 15:00

November 25, 2024 icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, [...]

Cofactor AI Launches Platform to Help Hospitals Fight Tidal Wave of Claims Denials and Announces $4 Million Seed Round

25/11/2024 - 15:00

Cofactor AI is leveling the playing field in the AI arms race between payers and providers CHICAGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hospitals across the country are facing an ever-increasing onslaught of claims [...]

Sharecare wins 17 Digital Health Awards in Fall 2024

25/11/2024 - 15:00

Company earns Gold for its NCQA-accredited disease management and population health capabilities, evidence-based digital therapeutics, and patient education content ATLANTA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sharecare, [...]

Teladoc Health Expands AI Capabilities for Hospitals and Health Systems with Advanced Virtual Sitter Solution

25/11/2024 - 14:30

New artificial intelligence (AI) capabilities help hospitals and health systems deliver safer and more efficient care PURCHASE, NY, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in [...]

MDxHealth to Participate in Piper Sandler Healthcare Conference

25/11/2024 - 14:30

MDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, [...]

Spinogenix Appoints American Football Hall of Famer and Health Advocate Steve Young to its Board of Directors

25/11/2024 - 14:30

LOS ANGELES, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of people worldwide, today [...]

QHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024

25/11/2024 - 14:30

Revenue Growth and APA Recognition Drive Momentum for QHSLab in 2024 WEST PALM BEACH, FL, Nov. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ) , an emerging leader in digital healthcare solutions [...]

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

25/11/2024 - 14:30

Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOS New pre-clinical data from the [...]

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

25/11/2024 - 14:30

TN-401 AAV9-based Gene Therapy Designed to Deliver Fully Functional PKP2 Gene with the Aim of Increasing Protein Levels to Address Underlying Disease RIDGE-1 Currently Enrolling at Six Centers; Observational Natural [...]

CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology

25/11/2024 - 14:30

VANCOUVER, Washington, Nov. 25, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns

25/11/2024 - 14:30

HAIFA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company leveraging its proprietary platform for cell-based solutions to create a [...]

Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

23/11/2024 - 01:11

- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of thyroxine and vitamin [...]

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

22/11/2024 - 23:15

FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications [...]

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

22/11/2024 - 22:45

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating [...]